Stock Market News News 21 December 2025

Pinterest (PINS) Stock News Today: S&P MidCap 400 Addition, tvScientific Deal, Analyst Price Targets, and the 2026 Outlook (Dec. 22, 2025)

Pinterest, Inc. (NYSE: PINS) is back in the spotlight on December 22, 2025—not because of a surprise earnings report, but because today is a “mechanical catalyst” day for the stock: Pinterest is officially being added to the S&P MidCap 400

22 December 2025

Analyst Ratings·Financial Outlook·Investment Strategies·Stock Market News

Ondas Holdings (ONDS) Stock News Today: Latest Deals, SEC Filings, and Analyst Forecasts as of Dec. 22, 2025

Updated: December 22, 2025 Ondas Holdings Inc. (NASDAQ: ONDS) has turned into one of the market’s more closely watched small-cap defense-tech stories after a rapid sequence of acquisitions, partnerships, and capital-structure updates that have kept the stock unusually active into

22 December 2025

Company Updates·Financial Reports·Investment Analysis·SEC Filings·Stock Market News

AST SpaceMobile (ASTS) Surges Ahead of ISRO’s BlueBird‑6 Launch: What Today’s News Signals for 2026—and the New Wave of Retail Risk-Taking

AST SpaceMobile (NASDAQ: ASTS) is back at the center of the “space-to-smartphone” trade on December 22, 2025, as a cluster of launch updates, market momentum, and retail-trader attention converge ahead of a high-profile mission involving India’s heavy-lift rocket LVM3 and

22 December 2025

Future Trends·Satellite Technology·Space Industry·Stock Market News

IREN Limited Stock (NASDAQ: IREN) News Today: Why Shares Are Moving on Dec. 22, 2025, Plus Analyst Forecasts and Key Catalysts

IREN Limited (NASDAQ: IREN) is back in the spotlight on Monday, December 22, 2025, as the stock extends a whiplash month for investors who’ve watched it swing from euphoric AI optimism to financing-driven volatility and back again. In pre-market trading,

22 December 2025

Analyst Forecasts·Financial Trends·Investment Analysis·Nasdaq Updates·Stock Market News

Amicus Therapeutics (FOLD) Stock on Dec. 22, 2025: BioMarin’s $14.50 Buyout, Latest News, Analyst Forecasts, and What’s Next

Dec. 22, 2025 — Amicus Therapeutics, Inc. (NASDAQ: FOLD) has abruptly shifted from a “rare-disease growth story” into a deal-driven stock, after BioMarin Pharmaceutical announced an all-cash agreement to acquire Amicus for $14.50 per share. With shares trading around $14.18

22 December 2025

Analyst Forecasts·Biotech Stocks·Investment Insights·Mergers & Acquisitions·Stock Market News

DCC Plc Stock (LSE: DCC) Update on Dec. 22, 2025: £600m Tender Offer Buyback Completed, Shares Cancelled, and Analysts’ 2026 Outlook

DCC Plc stock is back on investors’ radar heading into the year-end stretch after the FTSE 100 group completed a major £600 million tender-offer buyback and cancelled the repurchased shares—one of the largest single capital-return moves in the UK market

22 December 2025

Company Updates·Financial Outlook·Investment Analysis·Share Buybacks·Stock Market News

Vedanta Demerger Update Dec 22, 2025: NCLT Approval, 1:1 Share Entitlement, Dividend Signals and Silver Rally at Hindustan Zinc

Vedanta’s long-awaited demerger is no longer just a boardroom plan—it has crossed its biggest legal hurdle and is now firmly in “execution mode.” The Mumbai bench of the National Company Law Tribunal (NCLT) has sanctioned Vedanta Ltd’s revised demerger scheme,

22 December 2025

Corporate Actions·Dividend Updates·Investment Insights·Stock Market News

Ondas Holdings (ONDS) Stock News on Dec. 21, 2025: December Deals, Defense Expansion, and Analyst Forecasts for 2026

Dec. 21, 2025 — Ondas Holdings Inc. (NASDAQ: ONDS) has become one of the market’s more polarizing small-cap defense-tech stories: part autonomous drones, part counter-drone (“counter-UAS”), part ground robotics, and—often forgotten in the headlines—part private industrial wireless networking. December brought

21 December 2025

Company Updates·Defense Industry·Financial Forecasts·Investment Analysis·Stock Market News

Amicus Therapeutics Stock (FOLD) News: BioMarin’s $14.50 Cash Buyout, Deal Timeline, and the Latest Forecasts (Dec. 21, 2025)

As of Sunday, December 21, 2025, Amicus Therapeutics, Inc. (NASDAQ: FOLD) has effectively shifted from a “biotech story stock” to a deal-driven stock. The reason is simple and decisive: BioMarin Pharmaceutical (NASDAQ: BMRN) agreed to acquire Amicus in an all-cash

21 December 2025

Biotech Stocks·Investment Analysis·Mergers & Acquisitions·Pharmaceutical Industry·Stock Market News

Toronto Stock Exchange (TSX) Today: S&P/TSX Composite Hits a Record High, Holiday Trading Hours, and 2026 Forecasts — Dec. 21, 2025

TORONTO — Bay Street is heading into the Christmas-shortened trading week with the kind of momentum that makes both optimists and risk managers feel uncomfortably alive. On Friday, Canada’s benchmark S&P/TSX Composite Index closed at 31,755.77, up 1% on the

21 December 2025

Canadian Economy·Market Forecasts·Stock Market News·Trading Hours

NASDAQ Today (Dec. 21, 2025): Nasdaq Composite Near 23,300 Ahead of Nasdaq-100 Rebalance, Fed Signals, and Nasdaq’s 23-Hour Trading Proposal

The Nasdaq is heading into Christmas week with a familiar late-December cocktail: holiday-thin liquidity, a “Santa Claus rally” watch, and the kind of tech-led price action that can look calm in the headline… right up until it isn’t. By the

21 December 2025

Federal Reserve·Market Analysis·Nasdaq Updates·Stock Market News·Trading Strategies

Ondas Holdings (ONDS) Stock News Today: Why Shares Surged, Key Defense Catalysts, and Analyst Price Targets (Dec. 21, 2025)

Ondas Holdings Inc. (NASDAQ: ONDS) is ending December with the kind of small-cap volatility that makes both momentum traders and long-term defense-tech watchers lean closer to the screen. The stock closed Friday, Dec. 19 at $9.22, up 18.21% in one

21 December 2025

Analyst Insights·Defense Industry·Investment Strategies·Stock Market News·Technology Stocks

Stock Market News News 21 December 2025 - 22 December 2025